Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Retained Earnings (2020 - 2025)

Intelligent Bio Solutions has reported Retained Earnings over the past 5 years, most recently at -$52.0 million for Q2 2024.

  • For Q2 2024, Retained Earnings fell 8929.49% year-over-year to -$52.0 million; the TTM value through Jun 2024 reached -$52.0 million, down 8929.49%, while the annual FY2024 figure was -$52.0 million, 8929.49% down from the prior year.
  • Retained Earnings for Q2 2024 was -$52.0 million at Intelligent Bio Solutions, down from -$49.2 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$575496.0 in Q2 2023 and troughed at -$52.0 million in Q2 2024.
  • A 5-year average of -$20.3 million and a median of -$17.4 million in 2020 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: skyrocketed 96.74% in 2022 and later crashed 8929.49% in 2024.
  • Year by year, Retained Earnings stood at -$18.9 million in 2020, then skyrocketed by 96.18% to -$721387.0 in 2021, then tumbled by 4447.45% to -$32.8 million in 2022, then tumbled by 40.84% to -$46.2 million in 2023, then dropped by 12.47% to -$52.0 million in 2024.
  • Business Quant data shows Retained Earnings for INBS at -$52.0 million in Q2 2024, -$49.2 million in Q1 2024, and -$46.2 million in Q4 2023.